CeA

Carcinoembryonic antigen, abbreviated CEA, is a glycoprotein normally produced during fetal development. In healthy adults, serum levels are typically low. Elevated CEA levels can occur in a range of cancers, most notably colorectal cancer, but also in cancers of the pancreas, stomach, breast, lung, and ovaries, among other conditions such as smoking, inflammatory diseases, hepatitis, and inflammatory bowel disease. Because CEA is not specific for cancer, it is used primarily as a tumor marker to help monitor treatment response and detect recurrence in patients with previously elevated levels, rather than as a primary stand-alone diagnostic test.

Commissariat à l'Énergie Atomique et aux Énergies Alternatives (CEA) is a French state research organization established in 1945 to oversee nuclear energy development. It has since expanded to energy technologies, defense, information sciences, and life sciences. The CEA operates laboratories and centers across France, including Saclay and Grenoble, and collaborates with universities, industry, and international partners. As a public establishment, it is a major driver of France's scientific and technological innovation.

Council of Economic Advisers (CEA) is a U.S. government body within the Executive Office of the President that provides economic analysis and policy advice. The council prepares reports and briefings for the President and Congress, evaluates policy proposals, and outlines the current and projected state of the economy. Members are appointed by the President and typically carry out their duties in coordination with other federal agencies.